Sangamo Therapeutics Inc. buy Truist Financial Co.
Start price
15.08.23
/
50%
€0.93
Target price
15.08.24
€6.40
Performance (%)
-13.17%
End price
16.08.24
€0.81
Summary
This prediction ended on 16.08.24 with a price of €0.81. The price of Sangamo Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.17%. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sangamo Therapeutics Inc. | -15.248% | -15.248% | -58.174% |
| iShares Core DAX® | -3.809% | -1.472% | 6.060% |
| iShares Nasdaq 100 | 0.487% | 2.215% | 12.682% |
| iShares Nikkei 225® | -4.418% | 4.971% | 30.914% |
| iShares S&P 500 | 0.251% | 1.225% | 9.374% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Truist Financial Co. from $8.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for SGMO provided by MarketBeat
In the thread Trading Sangamo Bioscienes
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Truist_Financial_Co_ for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.12
23.01.25
23.01.25
€4.80
23.01.26
23.01.26
-71.24%
24.01.26
24.01.26
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.04
13.12.24
13.12.24
€6.66
13.12.25
13.12.25
-81.30%
14.12.25
14.12.25